Clinical Trials in Pittsburgh

Showing 12501-12520 of 18,076 trials

Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents

NCT00262041

The purpose of this study is to evaluate the safety and immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in comparison to licensed meningococcal polysaccharide vaccine administered to healthy adolescents ages 11 to 17 years.

Prevention of Meningococcal Disease

Novartis Vaccines524 participantsStarted Oct 2004

Rochester, Minnesota, United States • Pittsburgh, Pennsylvania, United States • Seattle, Washington, United States

COMPLETEDPhase 1< 1 mile

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

NCT00006025

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of temozolomide plus irinotecan in treating patients who have recurrent malignant glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Jan 2001

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +6 more locations

Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Find Trials by Condition in Pittsburgh

Early Versus Late Voiding Trials After Prolapse Repair

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Injection of Autologous Adipose Tissue for Treatment of Osteoarthritis in the Knee

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets